vs

Side-by-side financial comparison of FIRST INDUSTRIAL REALTY TRUST INC (FR) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.

FIRST INDUSTRIAL REALTY TRUST INC is the larger business by last-quarter revenue ($194.8M vs $151.7M, roughly 1.3× Nutex Health, Inc.). FIRST INDUSTRIAL REALTY TRUST INC runs the higher net margin — 75.9% vs 7.8%, a 68.1% gap on every dollar of revenue. On growth, FIRST INDUSTRIAL REALTY TRUST INC posted the faster year-over-year revenue change (10.0% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 8.9%).

First Potomac Realty Trust was a real estate investment trust that invested in industrial properties and business parks in the suburbs of the Washington metropolitan area. In 2017, it was acquired by Government Properties Income Trust.

Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.

FR vs NUTX — Head-to-Head

Bigger by revenue
FR
FR
1.3× larger
FR
$194.8M
$151.7M
NUTX
Growing faster (revenue YoY)
FR
FR
+51.1% gap
FR
10.0%
-41.1%
NUTX
Higher net margin
FR
FR
68.1% more per $
FR
75.9%
7.8%
NUTX
Faster 2-yr revenue CAGR
NUTX
NUTX
Annualised
NUTX
50.0%
8.9%
FR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FR
FR
NUTX
NUTX
Revenue
$194.8M
$151.7M
Net Profit
$147.9M
$11.8M
Gross Margin
30.4%
Operating Margin
20.4%
Net Margin
75.9%
7.8%
Revenue YoY
10.0%
-41.1%
Net Profit YoY
179.7%
-80.8%
EPS (diluted)
$1.08
$2.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FR
FR
NUTX
NUTX
Q1 26
$194.8M
Q4 25
$188.4M
$151.7M
Q3 25
$181.4M
$267.8M
Q2 25
$180.2M
$244.0M
Q1 25
$177.1M
$211.8M
Q4 24
$175.6M
$257.6M
Q3 24
$167.6M
$78.8M
Q2 24
$164.1M
$76.1M
Net Profit
FR
FR
NUTX
NUTX
Q1 26
$147.9M
Q4 25
$78.8M
$11.8M
Q3 25
$65.3M
$55.4M
Q2 25
$55.2M
$-17.7M
Q1 25
$48.1M
$21.2M
Q4 24
$68.4M
$61.6M
Q3 24
$99.4M
$-8.8M
Q2 24
$51.3M
$-364.0K
Gross Margin
FR
FR
NUTX
NUTX
Q1 26
Q4 25
30.4%
Q3 25
57.8%
Q2 25
51.2%
Q1 25
55.9%
Q4 24
55.0%
Q3 24
27.8%
Q2 24
29.7%
Operating Margin
FR
FR
NUTX
NUTX
Q1 26
Q4 25
34.6%
20.4%
Q3 25
37.0%
48.7%
Q2 25
31.7%
13.8%
Q1 25
31.2%
38.1%
Q4 24
40.1%
44.4%
Q3 24
62.6%
12.3%
Q2 24
31.8%
7.0%
Net Margin
FR
FR
NUTX
NUTX
Q1 26
75.9%
Q4 25
41.8%
7.8%
Q3 25
36.0%
20.7%
Q2 25
30.6%
-7.3%
Q1 25
27.2%
10.0%
Q4 24
39.0%
23.9%
Q3 24
59.3%
-11.2%
Q2 24
31.3%
-0.5%
EPS (diluted)
FR
FR
NUTX
NUTX
Q1 26
$1.08
Q4 25
$0.60
$2.34
Q3 25
$0.49
$7.76
Q2 25
$0.42
$-2.95
Q1 25
$0.36
$3.33
Q4 24
$0.51
$11.56
Q3 24
$0.75
$-1.72
Q2 24
$0.39
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FR
FR
NUTX
NUTX
Cash + ST InvestmentsLiquidity on hand
$185.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.9B
$329.4M
Total Assets
$5.8B
$918.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FR
FR
NUTX
NUTX
Q1 26
Q4 25
$78.0M
$185.6M
Q3 25
$33.5M
$166.0M
Q2 25
$34.9M
$96.7M
Q1 25
$35.7M
$84.7M
Q4 24
$44.5M
$40.6M
Q3 24
$47.1M
$46.9M
Q2 24
$38.5M
$40.8M
Stockholders' Equity
FR
FR
NUTX
NUTX
Q1 26
$2.9B
Q4 25
$2.7B
$329.4M
Q3 25
$2.7B
$317.2M
Q2 25
$2.6B
$235.3M
Q1 25
$2.7B
$176.9M
Q4 24
$2.7B
$132.4M
Q3 24
$2.6B
$60.4M
Q2 24
$2.6B
$62.7M
Total Assets
FR
FR
NUTX
NUTX
Q1 26
$5.8B
Q4 25
$5.7B
$918.5M
Q3 25
$5.5B
$964.5M
Q2 25
$5.5B
$841.0M
Q1 25
$5.4B
$761.9M
Q4 24
$5.3B
$655.3M
Q3 24
$5.2B
$438.5M
Q2 24
$5.2B
$422.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FR
FR
NUTX
NUTX
Operating Cash FlowLast quarter
$70.4M
Free Cash FlowOCF − Capex
$69.0M
FCF MarginFCF / Revenue
45.5%
Capex IntensityCapex / Revenue
0.9%
Cash ConversionOCF / Net Profit
5.95×
TTM Free Cash FlowTrailing 4 quarters
$245.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FR
FR
NUTX
NUTX
Q1 26
Q4 25
$461.3M
$70.4M
Q3 25
$124.6M
$99.5M
Q2 25
$126.1M
$27.3M
Q1 25
$88.6M
$51.0M
Q4 24
$352.5M
$54.0K
Q3 24
$105.5M
$6.8M
Q2 24
$107.7M
$13.3M
Free Cash Flow
FR
FR
NUTX
NUTX
Q1 26
Q4 25
$69.0M
Q3 25
$99.2M
Q2 25
$26.5M
Q1 25
$50.9M
Q4 24
$-341.0K
Q3 24
$6.2M
Q2 24
$12.7M
FCF Margin
FR
FR
NUTX
NUTX
Q1 26
Q4 25
45.5%
Q3 25
37.0%
Q2 25
10.9%
Q1 25
24.0%
Q4 24
-0.1%
Q3 24
7.8%
Q2 24
16.7%
Capex Intensity
FR
FR
NUTX
NUTX
Q1 26
Q4 25
0.9%
Q3 25
0.1%
Q2 25
0.3%
Q1 25
0.0%
Q4 24
0.2%
Q3 24
0.8%
Q2 24
0.7%
Cash Conversion
FR
FR
NUTX
NUTX
Q1 26
Q4 25
5.85×
5.95×
Q3 25
1.91×
1.80×
Q2 25
2.28×
Q1 25
1.84×
2.40×
Q4 24
5.15×
0.00×
Q3 24
1.06×
Q2 24
2.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FR
FR

Segment breakdown not available.

NUTX
NUTX

Hospital Division$143.7M95%
Population Health Management Division$8.0M5%

Related Comparisons